|
CTTNBP2NL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.417200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.516100E-02 |
| Normal-vs-Stage2 |
1.179560E-01 |
| Normal-vs-Stage3 |
9.215900E-02 |
| Normal-vs-Stage4 |
5.288600E-01 |
| Stage1-vs-Stage2 |
5.583400E-01 |
| Stage1-vs-Stage3 |
4.822600E-01 |
| Stage1-vs-Stage4 |
6.303800E-01 |
| Stage2-vs-Stage3 |
9.745600E-01 |
| Stage2-vs-Stage4 |
4.757000E-01 |
| Stage3-vs-Stage4 |
4.833600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.698200E-03 |
| Normal-vs-AfricanAmerican |
1.475980E-01 |
| Normal-vs-Asian |
8.765600E-01 |
| Caucasian-vs-AfricanAmerican |
2.452800E-01 |
| Caucasian-vs-Asian |
4.339200E-01 |
| AfricanAmerican-vs-Asian |
5.722200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.306100E-02 |
| Normal-vs-Female |
1.181290E-03 |
| Male-vs-Female |
6.057600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.202000E-01 |
| Normal-vs-Extreme_Weight |
1.173210E-01 |
| Normal-vs-Obese |
7.817900E-03 |
| Normal-vs-Extreme_Obese |
5.304200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.835400E-01 |
| Normal_Weight-vs-Obese |
9.642400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.402600E-01 |
| Extreme_Weight-vs-Obese |
1.500220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.228200E-01 |
| Obese-vs-Extreme_Obese |
4.482200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.418440E-01 |
| Normal-vs-Age(41-60Yrs) |
9.613100E-04 |
| Normal-vs-Age(61-80Yrs) |
6.251800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.096400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.892400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.784800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.671900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.403800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.303660E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.800000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.637950E-03 |
| Normal-VS-Type2 PRCC |
6.243200E-01 |
| Normal-VS-KIRP CIMP |
1.492040E-01 |
| Normal-VS-Unclassified PRCC |
7.103800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.737300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.364800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.576200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.930350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.445610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.638400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.667600E-01 |
| Normal-vs-N1 |
3.607900E-02 |
| Normal-vs-N2 |
1.629980E-01 |
| N0-vs-N1 |
9.790400E-02 |
| N0-vs-N2 |
4.190200E-01 |
| N1-vs-N2 |
8.583200E-01 |
|
|
